JPMorgan Chase & Co. Sells 27,903 Shares of Astrana Health, Inc. $ASTH

JPMorgan Chase & Co. trimmed its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 30.3% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 64,298 shares of the company’s stock after selling 27,903 shares during the quarter. JPMorgan Chase & Co. owned 0.11% of Astrana Health worth $1,823,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. 325 Capital LLC lifted its holdings in shares of Astrana Health by 34.6% in the 3rd quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock worth $33,849,000 after acquiring an additional 307,037 shares during the last quarter. SteelPeak Wealth LLC lifted its holdings in shares of Astrana Health by 7.8% in the 3rd quarter. SteelPeak Wealth LLC now owns 579,937 shares of the company’s stock worth $16,441,000 after acquiring an additional 41,761 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Astrana Health by 19.2% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 500,527 shares of the company’s stock worth $14,190,000 after acquiring an additional 80,465 shares during the last quarter. Ameriprise Financial Inc. increased its stake in shares of Astrana Health by 231.0% in the third quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock worth $12,540,000 after buying an additional 308,665 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC increased its stake in shares of Astrana Health by 44.2% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 421,710 shares of the company’s stock worth $11,955,000 after buying an additional 129,270 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Stock Up 6.7%

Shares of Astrana Health stock opened at $27.75 on Wednesday. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.25. The company’s fifty day simple moving average is $22.66 and its two-hundred day simple moving average is $25.27. The company has a market cap of $1.54 billion, a P/E ratio of 60.33 and a beta of 0.77. Astrana Health, Inc. has a 12-month low of $18.08 and a 12-month high of $34.80.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. The business had revenue of $950.53 million for the quarter, compared to the consensus estimate of $930.46 million. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The company’s quarterly revenue was up 42.9% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.15) EPS. Research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently commented on ASTH shares. Needham & Company LLC started coverage on shares of Astrana Health in a research note on Friday, December 12th. They issued a “buy” rating and a $28.00 target price on the stock. Truist Financial lifted their target price on shares of Astrana Health from $37.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, March 13th. BTIG Research decreased their target price on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Finally, Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $34.00.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.